Drug-eluting stents better than bare-metal stents for heart attack patients
Saturday, September 26, 2009 - 23:21
in Health & Medicine
SAN FRANCISCO, CA -- SEPTEMBER 25, 2009 -- Late-breaking data from the landmark HORIZONS-AMI clinical trial, presented at the 21st annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium, demonstrated that after two years, in heart attack patients, the use of a drug-eluting stent (paclitaxel) was safer and more effective than a bare-metal stent; and that the administration